Metallodrugs, Metallopharmaceuticals and Bio-Inspired Metal-organic Frameworks
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 6659
Special Issue Editor
2. Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento (IST-ID), Av. Rovisco Pais 1, 1049-003 Lisbon, Portugal
Interests: mechanochemistry; crystal engineering; supramolecular chemistry; BioMOFs; polymorphs; co-crystals; metallodrugs and metallopharmaceuticals; Antibiotic Coordination Frameworks (ACFs)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metallodrugs, metallopharmaceuticals, and bio-inspired metal–organic frameworks (BioMOFs) can play an important role in the quest for more efficient and cost-effective therapeutics, a very demanding issue within the pharmaceutical industry.
Even though the use of metal-containing compounds for pharmaceutical applications is long-known, these forms are much less explored than organic molecules. Metallodrugs and metallopharmaceuticals have been reported as effective systems to battle several diseases, such as cancer and infectious illnesses. BioMOFs are groundbreaking materials that have recently been explored for drug storage, delivery, and controlled release, as well as for applications in imaging and sensing for therapeutics and diagnostics. BioMOFs can further be used to enhance the properties of currently available forms.
Traditionally, the synthesis of such compounds is based on solution techniques. However, sustainable procedures, such as mechanochemistry and microwave-assisted synthesis, have been presented as promising and advantageous alternatives.
The aim of this Special Issue is to report the most recent developments in metallodrugs, metallopharmaceuticals, and BioMOFs, and to show how they can contribute to the pharmaceutical industry. The use of sustainable synthetic techniques is encouraged.
Dr. Vânia André
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Metallopharmaceuticals
- Metallodrugs
- Bio-inspired metal–organic frameworks
- Drug properties
- Sustainable synthesis
